Status:

COMPLETED

The Role of Apathy in Glycemic Control

Lead Sponsor:

US Department of Veterans Affairs

Conditions:

Apathy

Diabetes

Eligibility:

All Genders

21-75 years

Phase:

NA

Brief Summary

In spite of several new medications and insulins for the control of blood sugars in patients with diabetes, a large number of patients do not have good control. This likely due to inability to carry o...

Detailed Description

The incidence of diabetes in the US is at epidemic proportions. A large number of diabetes patients in the VA system have uncontrolled diabetes with high HbA1c. The inability to carry out important se...

Eligibility Criteria

Inclusion

  • Poor glycemic control HbA1c\>8
  • Presence of apathy, a score of \>30 on AES
  • Subjects should be on stable dose of metformin, thiozolidinediones, and sulfonylureas, statins and ACE inhibitors for at least two months
  • Subjects should have a negative cardiac stress test within the previous year

Exclusion

  • Presence of major depressive disorder, psychosis, suicidal ideations, and history of stimulant dependence as evaluated by MINI.
  • Patient currently being treated or a history hypersensitivity to methylphenidate
  • Hypertension with BP\>140/90
  • History of renal disease with GFR\<60
  • History of hepatic failure with AST/ALT \> three times the normal range
  • History of seizure disorder, or Tourette's syndrome or presence of motor tics
  • Patients with glaucoma
  • Patients being treated with monoamine oxidase inhibitors (MAOIs) or Clonidine
  • Patients with active cancer.
  • Patients with acute illness needing hospitalization
  • Patients with cardiovascular events such as myocardial infarction, stroke, amputation, unstable angina within the last six months.
  • HbA1c\> 12
  • Planned elective surgery in next 6 months
  • Pregnancy

Key Trial Info

Start Date :

July 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2012

Estimated Enrollment :

106 Patients enrolled

Trial Details

Trial ID

NCT00844090

Start Date

July 1 2009

End Date

October 1 2012

Last Update

April 21 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

VA Medical Center, Omaha

Omaha, Nebraska, United States, 68105-1873